11 assets in Intracranial Arteriosclerosis

Therapeutic assets addressing Intracranial Arteriosclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aspirin Intracranial Arteriosclerosis	Yonsei University	P4	BBB (73)
Clopidogrel Intracranial Arteriosclerosis	Yonsei University	P4	BB (71)
Apixaban Intracranial Arteriosclerosis	Yonsei University	P4	BB (65)
Rivaroxaban Intracranial Arteriosclerosis	University of Florida	P3	BB (64)
Atorvastatin Intracranial Arteriosclerosis	The First Affiliated Hospital with Nanjing Medical University	P3	B (60)
Evolocumab Intracranial Arteriosclerosis	The First Affiliated Hospital with Nanjing Medical University	P3	B (60)
Ticagrelor Intracranial Arteriosclerosis	University of Florida	P3	B (60)
Tocilizumab Intracranial Arteriosclerosis	Zhujiang Hospital	P3	B (60)
Physiologic Sodium Chloride Solution Intracranial Arteriosclerosis	Zhujiang Hospital	P3	B (58)
K-13675, (R)- Intracranial Arteriosclerosis	Tokyo Women's Medical University	N/A	D (30)